TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s December 12, 1997